Skip to main content
. 2019 Apr 3;17(6):4877–4890. doi: 10.3892/ol.2019.10211

Figure 1.

Figure 1.

CX3CL1 mRNA expression levels in LUAD and at Tumour Node Metastasis stages. (A) Patients with LUAD had significantly decreased mRNA expression levels of CX3CL1 in tumour tissues compared with normal tissue (t=10.259, P<0.001). (B) No significant difference was shown in different clinical stages (F=3.512, P=0.062). CX3CL1, chemokine C-X3-C motif ligand 1; LUAD, lung adenocarcinoma.